Literature DB >> 14319404

STUDIES ON DELAYED HYPERSENSITIVITY. I. INFERENCES ON THE COMPARATIVE BINDING AFFINITIES OF ANTIBODIES MEDIATING DELAYED AND IMMEDIATE HYPERSENSITIVITY REACTIONS IN THE GUINEA PIG.

B B LEVINE.   

Abstract

Experiments carried out with several well defined antigenic systems (hapten conjugates of poly-L-lysine and guinea pig serum albumin) in guinea pigs demonstrated that: 1. Arthus reactions also manifest carrier specificity, although to a smaller extent than do delayed hypersensitivity reactions. 2. Desensitization by injection of minute doses of antigen results in moderate specific desensitization of delayed hypersensitivity without desensitization of Arthus reactivity to the same antigenic determinant. 3. Insoluble antigen-antibody complexes prepared from high affinity guinea pig antibodies can elicit specific delayed skin reactions in sensitized guinea pigs. 4. Homologous conjugates of structurally similar haptens show considerably less cross-reactivity in delayed reactions than in immediate hypersensitivity reactions to the same antigenic determinant. These experimental results are interpreted as indicating that delayed hypersensitivity reactions in the guinea pig are mediated by "antibodies" of comparatively high binding affinities. High binding affinities are achieved for these antibodies more likely by closer structural adaptation between antigen and antibody than by a larger area of specific contact.

Entities:  

Keywords:  ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; ARTHUS PHENOMENON; DINITROPHENOLS; EXPERIMENTAL LAB STUDY; GUINEA PIGS; HAPTENS; HYPERSENSITIVITY; HYPERSENSITIVITY, DELAYED; HYPERSENSITIVITY, IMMEDIATE; NITROBENZENES; PEPTIDES; SERUM ALBUMIN

Mesh:

Substances:

Year:  1965        PMID: 14319404      PMCID: PMC2138010          DOI: 10.1084/jem.121.6.873

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  STUDIES ON THE IMMUNOLOGICAL MECHANISMS OF PENICILLIN ALLERGY. I. ANTIGENIC SPECIFICITIES OF GUINEA-PIG SKIN SENSITIZING RABBIT ANTI-BENZYLPENICILLIN ANTIBODIES.

Authors:  B B LEVINE
Journal:  Immunology       Date:  1964-09       Impact factor: 7.397

2.  BASIS FOR THE ANTIGENICITY OF HAPTEN-POLY-L-LYSINE CONJUGATES IN RANDOM-BRED GUINEA PIGS.

Authors:  B B LEVINE; A OJEDA; B BENACERRAF
Journal:  Nature       Date:  1963-11-09       Impact factor: 49.962

3.  Heterogeneity in extent of the combining regions of human antidextran.

Authors:  E A KABAT
Journal:  J Immunol       Date:  1956-12       Impact factor: 5.422

4.  Studies of hypersensitivity to low molecular weight substances. III. The 2,4-dinitrophenyl group as a determinant in the preciptin reaction.

Authors:  H N EISEN; M E CARSTEN; S BELMAN
Journal:  J Immunol       Date:  1954-11       Impact factor: 5.422

5.  Delayed hypersensitivity to hapten-protein conjugates. I. The effect of carrier protein and site of attachment to hapten.

Authors:  P G GELL; A M SILVERSTEIN
Journal:  J Exp Med       Date:  1962-05-01       Impact factor: 14.307

6.  The specificity of allergic reactions. I. Delayed versus Arthus hypersensitivity.

Authors:  S B SALVIN; R F SMITH
Journal:  J Exp Med       Date:  1960-04-01       Impact factor: 14.307

7.  Studies on the dimensions of the rabbit antibenzylpenicilloyl antibody-combing sites.

Authors:  B B LEVINE
Journal:  J Exp Med       Date:  1963-01-01       Impact factor: 14.307

8.  Delayed hypersensitivity. III. Specific desensitization of guinea pigs sensitized to protein antigens.

Authors:  J W UHR; A M PAPPENHEIMER
Journal:  J Exp Med       Date:  1958-12-01       Impact factor: 14.307

9.  Immunological specificity of delayed and immediate hypersensitivity reactions.

Authors:  B BENACERRAF; B B LEVINE
Journal:  J Exp Med       Date:  1962-05-01       Impact factor: 14.307

10.  Delayed hypersensitivity to hapten-protein conjugates. II. Anti-hapten specificity and the heterogeneity of the delayed response.

Authors:  A M SILVERSTEIN; P G GELL
Journal:  J Exp Med       Date:  1962-05-01       Impact factor: 14.307

View more
  8 in total

1.  Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.

Authors:  Abraham Jacob; Janet Oblinger; Matthew L Bush; Victoria Brendel; Griffin Santarelli; Abhik R Chaudhury; Samuel Kulp; Krista M D La Perle; Ching-Shih Chen; Long-Sheng Chang; D Bradley Welling
Journal:  Laryngoscope       Date:  2011-11-22       Impact factor: 3.325

2.  AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.

Authors:  Matthew L Bush; Janet Oblinger; Victoria Brendel; Griffin Santarelli; Jie Huang; Elena M Akhmametyeva; Sarah S Burns; Justin Wheeler; Jeremy Davis; Charles W Yates; Abhik R Chaudhury; Samuel Kulp; Ching-Shih Chen; Long-Sheng Chang; D Bradley Welling; Abraham Jacob
Journal:  Neuro Oncol       Date:  2011-07-21       Impact factor: 12.300

3.  Studies on the effect of the carrier molecule on antihapten antibody synthesis. II. Carrier specificity of anti-2,4-dinitrophenyl-poly-l-lysine antibodies.

Authors:  W E Paul; G W Siskind; B Benacerraf
Journal:  J Exp Med       Date:  1966-04-01       Impact factor: 14.307

4.  Passive transfer of experimental allergic thyriditis, delayed hypersensitivity to thyroglobulin and anti-thyroglobulin antibody formation in inbred Lewis rats.

Authors:  B D Janković; K Mitrović; L Popesković; D Milosević
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

5.  Hapten-specific stimulation of secondary B cells independent of T cells.

Authors:  N R Klinman; R A Doughty
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

6.  Carrier function in anti-hapten immune responses. I. Enhancement of primary and secondary anti-hapten antibody responses by carrier preimmunization.

Authors:  D H Katz; W E Paul; E A Goidl; B Benacerraf
Journal:  J Exp Med       Date:  1970-08-01       Impact factor: 14.307

7.  Studies on the effect of the carrier molecule on antihapten antibody synthesis. I. Effect of carrier on the nature of the antibody synthesized.

Authors:  G W Siskind; W E Paul; B Benacerraf
Journal:  J Exp Med       Date:  1966-04-01       Impact factor: 14.307

8.  Immunologic competence of thoracic duct cells. I. Delayed hypersensitivity.

Authors:  J E Coe; J D Feldman; S Lee
Journal:  J Exp Med       Date:  1966-02-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.